Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Clinical trial NCT01782235 · COMPLETED
Trial details
- NCT number
- NCT01782235
- Sponsor
- University Hospital, Strasbourg, France
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-24
- Primary completion
- 2018-07-16
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.